Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors

Neuropharmacology

Volumn 43, Issue 8, 2002, Pages 1258-1268

  Ripley, Tamzin L ^a   Gadd, Christopher A ^b   De Felipe, Carmen ^c   Hunt, Stephen P ^b   Stephens, David N ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Drug abuse; Drug addiction; Opiate; Substance P

Indexed keywords

COCAINE; MORPHINE SULFATE; NEUROKININ 1 RECEPTOR; OPIATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; LEARNING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REWARD; SENSITIZATION; TASK PERFORMANCE; WILD TYPE;

EID: 0036951193     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00295-2     Document Type: Article

References (45)

1. Airio J., Ahtee L. Role of cerebral dopamine and noradrenaline in the morphine-induced locomotor sensitisation in mice. Pharmacology and Biochemical Behavior. 58:1997;379-386.
2. 1 receptor antagonist. European Journal of Pharmacology. 412:2001;255-264.
3. Bechara A., van der Kooy D. The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. Journal of Neuroscience. 9:1989;3400-3409.
4. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
5. Boix F., Sandor P., Nogueira P.J.C., Huston J.P., Schwarting R.K.W. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience. 64:1995;1045-1055.
6. Crow T.J., Spear P.J., Arbuthnott G.W. Intracranial self-stimu;lation in the region of the locus coeruleus. Brain Research. 36:1972;275-287.
7. Darmani N.A., Pandya D.K. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. Journal of Neural Transmission. 107:2000;931-945.
8. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J., Laird J.M., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
9. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., Vanderschuren L.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. European Journal of Neuroscience. 10:1998;3565-3571.
10. Froger N., Gardier A.M., Moratalla R., Alberti I., Lena I., Boni C., De Felipe C., Rupniak N.M., Hunt S.P., Jacquot C., Hamon M., Lanfumey L. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. Journal of Neuroscience. 21:2001;8188-8197.
11. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends in Neuroscience. 19:1996;177-181.
12. Gong W.H., Neill D., Justice J.B. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Research. 707:1996;64-74.
13. Haddjeri N., Blier P. Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biology and Psychiatry. 50:2001;191-199.
14. Hasenrohrl R.U., Frisch C., Huston J.P. Evidence for anatomical specificity for the reinforcing effects of SP in the nucleus basalis magnocellularis. Neuroreport. 9:1998;7-10.
15. Hasenrohrl R.U., Gerhardt P., Huston J.P. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence. Experimntal Neurology. 115:1992;282-291.
16. Herberg L.J., Stephens D.N., Franklin K.B.J. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacology and Biochemical Behavior. 4:1975;575-582.
17. Kalivas P.W., Churchill L., Klitenick M.A. The circuitary mediating the translation of motivational stimuli into adaptive motor responses. Kalivas P.W., Barnes C.D. Limbic Motor Circuits and Neuropsychiatry. 1993;237-287 CRC Press, Boca Raton, FL.
18. Kalivas P.W. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Dependence. 37:1995;95-100.
19. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404.
20. Lu L., Xu N.J., Ge X., Yue W., Su W.J., Pei G., Ma L. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology (Berl). 159:2002;125-132.
21. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. European Journal of Neuroscience. 12:2000;4038-4046.
22. Moyse E., Marcel D., Leonard K., Beaudet A. Electron microscopic distribution of mu opioid receptors on noradrenergic neurons of the locus coeruleus. European Journal of Neuroscience. 9:1997;128-139.
23. Murtra P., Sheasby A.M., Hunt S.P., De Felipe C. Loss of rewarding effects of morphine and amphetamine, but not cocaine, in mice with disruption of the substance P receptor (NK1) gene. Society of Neuroscience Abstracts. 26:2000;1769.
24. Murtra P., Sheasby A.M., Hunt S.P., De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature. 405:2000;180-183.
25. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. Journal of Compative Neurology. 347:1994;249-274.
26. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
27. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. National Review of Neuroscience. 2:2001;119-128.
28. Nestler E.J., Alreja M., Aghajanian G.K. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Research Bulletin. 35:1994;521-528.
29. Nestler E.J., Alreja M., Aghajanian G.K. Molecular control of locus coeruleus neurotransmission. Biological Psychiatry. 46:1999;1131-1139.
30. Nestler E.J., Hope B.T., Widnell K.L. Drug addiction: a model for the molecular basis of neural plasticity. Neuron. 11:1993;995-1006.
31. Olmstead M.C., Franklin K.B.J. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behavioral Neuroscience. 111:1997;1324-1334.
32. Papp M., Vassout A., Gentsch C. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behavioral Brain Research. 115:2000;19-23.
33. Parker J.L., van der Kooy D. Tegmental pedunculopontine nucleus lesions do not block cocaine reward. Pharmacology and Biochemical Behavior. 52:1995;77-83.
34. Ritter S., Stein L. Self-stimulation of noradrenergic cell group (A6) in locus coeuleus of rats. Journal of Comparative Physiology and Psychology. 85:1972;443-452.
35. Rocha B.A., Ator R., Emmett-Oglesby M.W., Hen R. Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacology and Biochemical Behavior. 57:1997;407-412.
36. 1) antagonists. Trends in Pharmacological Science. 20:1999;485-490.
37. 1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology. 39:2000;1413-1421.
38. Santarelli L., Gobbi G., Debs P.C., Sibille E.T., Blier P., Hen R., Heath M.J. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proceedings of the National Academy of Science of the U. S. A. 98:2001;1912-1917.
39. Sills T.L., Fletcher P.J. Fluoxetine attenuates morphine-induced locomotion and blocks morphine- sensitization. European Journal of Pharmacology. 337:1997;161-164.
40. Trujillo K.A. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl). 151:2000;121-141.
41. Tzschentke T.M., Schmidt W.J. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801- but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm. Behavioral Brain Research. 97:1998;115-127.
42. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 151:2000;99-120.
43. Vanderschuren L.J., Schoffelmeer A.N., Mulder A.H., De Vries T.J. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl). 143:1999;244-253.
44. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Progress in Neurobiology. 54:1998;679-720.
45. Zhou Q., Nyberg F. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal. Neuroscience Letters. 320:2002;117-120.